BarondesSHCastronovoVCooperDNCummingsRDDrickamerKFeiziT: Galectins: A family of animal beta-galactoside-binding lectins. Cell1994; 76: 597–598.
2.
CalificeSCastronovoVVan Den BruleF: Galectin-3 and cancer (review). Int J Oncol2004; 25: 983–992.
3.
HughesRC: Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta1999; 1473: 172–185.
4.
DebrayCVereeckenPBelotNTeillardPBrionJPPandolfoM: Multifaceted role of galectin-3 on human glioblastoma cell motility. Biochem Biophys Res Commun2004; 325: 1393–1398.
5.
PerilloNLMarcusMEBaumLG: Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med1998; 76: 402–412.
6.
IurisciITinariNNatoliCAngelucciDCianchettiEIacobelliS: Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin Cancer Res2000; 6: 1389–1393.
7.
VereeckenPDebrayCPeteinMAwadaALalmandMCLaporteM: Expression of galectin-3 in primary and metastatic melanoma: Immunohistochemical studies on human lesions and nude mice xenograft tumors. Arch Dermatol Res2005; 296: 353–358.
8.
BarondesSHCooperDNGittMALefflerH: Galectins. Structure and function of a large family of animal lectins. J Biol Chem1994; 269: 20807–20810.
9.
AlmkvistJKarlssonA: Galectins as inflammatory mediators. Glycoconj J2004; 19: 575–581.
10.
MatarresePFuscoOTinariNNatoliCLiuFTSemeraroML: Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int J Cancer2000; 85: 545–554.
11.
SulaimonSSKitchellBE: The basic biology of malignant melanoma: Molecular mechanisms of disease progression and comparative aspects. J Vet Intern Med2003; 17: 760–772.
12.
AlonsoSROrtizPPollanMPerez-GomezBSanchezLAcunaMJ: Progression in cutaneous malignant melanoma is associated with distinct expression profiles: A tissue microarray-based study. Am J Pathol2004; 164: 193–203.
